
Please try another search
Poltreg S.A., a biotechnology company, researches and develops therapies for autoimmune diseases. It engages in the development of therapies for the treatment of type 1 diabetes in children, and multiple sclerosis. The company was incorporated in 2016 and is based in Gdansk, Poland.
Name | Age | Since | Title |
---|---|---|---|
Artur Janusz Osuchowski | - | 2021 | Independent Supervisory Board Member |
Oktawian Zbigniew Jaworek | - | 2021 | Supervisory Board Member |
Marcin Jerzy Mierzwinski | - | 2021 | Chairman of the Supervisory Board |
Wojciech Golak | - | 2023 | Members of the Supervisory Board |
Michal Wnorowski | - | 2024 | Independent Member of the Supervisory Board |
Pawel Mandok | - | 2024 | Independent Member of the Supervisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review